Cargando…
A Case of Ferumoxytol (Feraheme(®)) Prompting Critical Modification to Our Patient Prebreast Magnetic Resonance Imaging Questionnaire
Apparent gadolinium-based contrast enhancement was seen on precontrast-enhanced images on two breast magnetic resonance imaging (MRI) for a patient done 1 week apart. This was caused by ferumoxytol, which is used to treat some anemias. Such nongadolinium-based therapeutics exhibiting unintended MRI...
Autores principales: | Samreen, Naziya, Bhatt, Asha A, Glockner, James, Lee, Christine U |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Scientific Scholar
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702869/ https://www.ncbi.nlm.nih.gov/pubmed/31448157 http://dx.doi.org/10.25259/JCIS-9-6 |
Ejemplares similares
-
Materials Characterization of Feraheme/Ferumoxytol and Preliminary Evaluation of Its Potential for Magnetic Fluid Hyperthermia
por: Bullivant, John P., et al.
Publicado: (2013) -
Nonconventional Options for Tumor Localization in Breast and Axillary Lymph Nodes: A Pictorial How-To
por: Samreen, Naziya, et al.
Publicado: (2018) -
A Clinical Approach to Diffusion-Weighted Magnetic Resonance Imaging in Evaluating Chest Wall Invasion of Breast Tumors
por: Samreen, Naziya, et al.
Publicado: (2019) -
Ferumoxytol-enhanced magnetic resonance imaging in acute myocarditis
por: Stirrat, Colin G, et al.
Publicado: (2018) -
Ferumoxytol enhanced black-blood cardiovascular magnetic resonance imaging
por: Nguyen, Kim-Lien, et al.
Publicado: (2017)